**Core Concept:** Physiological antagonism refers to the phenomenon where a drug with similar pharmacological properties to a neurotransmitter or hormone can prevent its effects without causing any adverse effects itself. This can be explained through competitive binding at the receptor site.

**Why the Correct Answer is Right:** In this question, we are discussing physiological antagonism between isoprenaline (a beta-agonist) and propranolol (a beta-blocker). Isoprenaline and propranolol are both beta-adrenergic agonists and antagonists, respectively. When isoprenaline is present, it activates beta-adrenergic receptors, leading to a cascade of physiological effects such as increased heart rate and contractility. Propranolol, as a beta-blocker, competes with isoprenaline for binding to beta-adrenergic receptors, effectively preventing isoprenaline's actions without causing its own actions.

**Why Each Wrong Option is Incorrect:**

A. Isoprenaline and salbutamol: Salbutamol is a beta-agonist, similar to isoprenaline, so it cannot exhibit physiological antagonism.
B. Isoprenaline and adrenaline: Adrenaline is a more potent beta-agonist than isoprenaline, so it will not exhibit physiological antagonism.
C. Isoprenaline and propranolol: As explained above, propranolol acts as a beta-blocker and exhibits physiological antagonism when combined with isoprenaline.
D. Adrenaline and histamine: Histamine is a different neurotransmitter and does not share the same receptor-binding properties as isoprenaline or adrenaline.

**Clinical Pearl:** Understanding physiological antagonism helps explain the concept of using beta-blockers like propranolol in the management of hypertension, arrhythmias, and myocardial infarction, where the goal is to inhibit the effects of catecholamines without causing their effects.